Multiple Dose Bioequivalence Trial Comparing a Down-Scaled New Analgesic Transdermal Patch Formulation to an Analgesic Reference Patch (Protocol ID: 855509)

Trial Profile

Multiple Dose Bioequivalence Trial Comparing a Down-Scaled New Analgesic Transdermal Patch Formulation to an Analgesic Reference Patch (Protocol ID: 855509)

Discontinued
Phase of Trial: Phase I

Latest Information Update: 15 Nov 2007

At a glance

  • Drugs Buprenorphine (Primary)
  • Indications Pain
  • Focus Pharmacokinetics
  • Sponsors Grunenthal
  • Most Recent Events

    • 15 Nov 2007 Status changed from in progress to discontinued.
    • 15 Nov 2007 The expected completion date for this trial has been extended from 1 Jul 2007 to 1 Nov 2007.
    • 21 Jul 2007 Status changed from recruiting to in progress.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top